SUBINTRO
Subintro is a biotechnology company that specializes in the development and delivery of antiviral therapeutics for RNA viruses that cause respiratory diseases such as influenza, RSV, rhinovirus, and SARS-CoV-2.
Similar Organizations
Aldebaran Therapeutics
Aldebaran Therapeutics is a biotechnology company.
Foresite Labs
Foresite Labs is a biotechnology company.
Hengenix
Hengenix is a biotechnology company.
Shanghai Zhijiang Biotechnology
Shanghai Zhijiang Biotechnology is engaged in R&D, production & sales of molecular diagnostic reagents, instruments and equipment.
Sunshine Earth Labs
Sunshine Earth Labs is a biosciences company.
T-Cure Biosciences
T-Cure Biosciences is a Biotechnology Company.
The Liver Company
The Liver Company is a biotechnology company.
VemiCo
VemiCo is a biotechnology company.
More informations about "Subintro"
Subintro - Crunchbase Company Profile & Funding
Organization. Subintro . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. About. Subintro is a biotechnology company. Acquired by . RIGImmune . Private; 2,281,027; ... Subintro is a biotechnology company that specializes in the development and …See details»
Subintro Company Profile 2024: Valuation, Investors, Acquisition ...
Subintro General Information Description. Provider of biotechnological services intended to prevent virus infection and tumors. The company is developing stem-loop RNA therapeutics …See details»
Subintro - Products, Competitors, Financials, Employees, …
Sep 16, 2022 About Subintro. Subintro is a biotechnology company specializing in the development and delivery of antiviral therapeutics for respiratory diseases caused by RNA …See details»
RIGImmune acquires antiviral company Subintros - BioCT
RIGImmune acquires antiviral company Subintros. RIGImmune has acquired Subintro, a biotechnology company specializing in the development and delivery of antiviral therapeutics …See details»
RIGImmune Announces Acquisition of Antiviral Company
FARMINGTON, Conn., Sept. 15, 2022 (GLOBE NEWSWIRE) -- RIGImmune Inc., a biopharmaceutical company developing a new class of RNA immunotherapeutics, today …See details»
SUBINTRO LIMITED overview - Find and update company …
People for SUBINTRO LIMITED (13357376) More for SUBINTRO LIMITED (13357376) Registered office address 33 Foley Street, C/- F-Prime Capital, London, England, W1W 7TL . …See details»
RIGImmune acquires Subintro - 2022-09-15 - Crunchbase
RIGImmune acquires Subintro on 2022-09-15 for an undisclosed amount. Search Crunchbase. Start Free Trial . Chrome Extension ... Overview. Edit Overview Section. Acquired …See details»
RIGImmune Announces Acquisition of Antiviral Company Subintro …
Sep 15, 2022 Newly formed company founded by prominent Yale professors will advance development of novel RNA therapies and vaccine adjuvants for local mucosal …See details»
Subintro Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Subintro Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Gunderson Dettmer Advises RIGImmune in its …
Sep 15, 2022 In the announcement of the acquisition, President of RIGImmune Susan Sobolov said, “Joining with the experienced Subintro team will allow us to further advance our development of new treatments, prophylactics and …See details»
SUBINTRO LIMITED Company Profile - Dun & Bradstreet
Subintro limited. d&b business directory home / business directory / professional, scientific, and technical services / scientific research and development services / united kingdom / london / …See details»
RIGImmune subsumes Subintro in nasal drug delivery buyout
Sep 19, 2022 RIGImmune has identified Subintro as a company that can support and expand its plans. Specifically, the acquired company has antivirals and delivery technologies that …See details»
RIGImmune Announces Acquisition of Antiviral Company Subintro
Subintro will become a wholly owned subsidiary of RIGImmune and Nihal Sinha, Ph.D. from F-Prime Capital will join the board of RIGImmune. RIGImmune is a platform biopharmaceutical …See details»
Rigimmune’s acquisition of Subintro helps close the stem-loop
Oct 27, 2022 Subintro’s technology allows the company to consider topical, nasal delivery. The combined company will be able to further advance compounds designed to activate the natural …See details»
Subintro - Updates, News, Events, Signals & Triggers - Crunchbase
Subintro is a biotechnology company. Recent News & Activity. Edit Recent News & Activity SectionSee details»
SUBINTRO LIMITED - Company Credit Reports, Company …
SUBINTRO LIMITED. COMPANY NUMBER 13357376. COMPANY TYPE Private limited with Share Capital. BUSINESS ACTIVITY (SIC) 72110 - Research and experimental development …See details»
RIG-101 - Drug Targets, Indications, Patents - Synapse - Patsnap
The lead development candidate at RIGImmune is RIG-101 and the company is developing an intranasal formulation with the acquisition of antiviral company Subintro. The company was co …See details»
RIGImmune acquires antiviral company Subintro
Sep 16, 2022 As part of the Subintro transaction, F-Prime Capital made an undisclosed investment in RIGImmune. Subintro co-founder and CEO and F-Prime Capital entrepreneur-in …See details»
SUBINTRO LIMITED - Reporting Accounts
SUBINTRO LIMITED are an established Private Limited Company who have traded for 3 years. Their area of operation is the Research and experimental development on biotechnology …See details»
Right on the nose: Rigimmune’s acquisition of Subintro ... - BioWorld
With its acquisition of Subintro Ltd., Rigimmune Inc. put a building block in place to further its development of stem-loop RNA therapeutics that selectively activate the innate immune …See details»